Open Payments

CHILDRENS HOSPITAL

Type
Teaching hospital
Where
Washington, DC
Medicare CCN
093300
Received
$1,830,804 in 393 records, 2023 ($746,488 general, $1,084,315 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2023General payment81$746,488
2023Research payment312$1,084,315

By company

CompanyRecordsAmountYears
Novartis Pharmaceuticals Corporation18$757,8412023
Takeda Pharmaceuticals U.S.A., Inc.2$666,2502023
Hikma Pharmaceuticals USA4$183,9612023
RADIOMETER AMERICA, INC1$41,4172023
Fisher Scientific Company L.L.C.36$32,7002023
Siemens Medical Solutions USA, Inc.2$32,0962023
Novo Nordisk AS172$31,4502023
KLS-Martin L.P.18$20,6182023
E.R. Squibb & Sons, L.L.C.2$9,5002023
National Marrow Donor Program4$9,1352023
Berlin Heart Inc1$8,5002023
MED-EL Corporation1$7,9502023
Travere Therapeutics, Inc.2$5,3482023
JAZZ PHARMACEUTICALS INC.103$4,4082023
Eli Lilly and Company1$4,0002023
Abbott Laboratories1$3,5002023
RECORDATI_RARE_DISEASES_INC.2$3,4002023
PFIZER INC.6$3,0292023
SANOFI PASTEUR INC.1$1,5002023
Merck Sharp & Dohme LLC2$1,2502023
Zimmer Biomet Holdings, Inc.2$1,0692023
Linvatec Corporation1$6842023
Stryker Corporation1$3902023
Smith+Nephew, Inc.2$3632023
Cochlear Americas1$1362023
GE HEALTHCARE1$1002023
Olympus America Inc.3$882023
Becton, Dickinson and Company1$512023
Baxter Healthcare1$362023
Bio-Rad Laboratories, Inc.1$262023

By nature of payment

NatureRecordsAmount
Research payment312$1,084,315
Grant1$650,000
Consulting Fee37$36,200
Long term medical supply or device loan21$29,290
Charitable Contribution1$15,000
Compensation for services other than consulting, including serving as faculty or as a speaker at a v4$9,135
Space rental or facility fees (teaching hospital only)4$4,250
Debt forgiveness12$2,562
Education1$51

Records

DateCompanyAmountNatureFormProductStudyYear
2023-12-31Siemens Medical Solutions USA, Inc.$31,709Research paymentIn-kind items and servicesArtis zee multi-purpose Device, AT - Fixed interventional x-ray/angiography fluoroscopyCNMC Kanter AX Interventional Cardiology2023
2023-12-31Linvatec Corporation$684Long term medical supply or device loanIn-kind items and servicesHALL POWER Device, ORTHOPEDIC SURGERY2023
2023-12-31Stryker Corporation$390Debt forgivenessCash or cash equivalent2023
2023-12-31Siemens Medical Solutions USA, Inc.$387Debt forgivenessIn-kind items and services2023
2023-12-31Novartis Pharmaceuticals Corporation$8Research paymentIn-kind items and servicesA Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Patients 2023
2023-12-29Zimmer Biomet Holdings, Inc.$630Debt forgivenessCash or cash equivalent2023
2023-12-29Zimmer Biomet Holdings, Inc.$439Debt forgivenessCash or cash equivalent2023
2023-12-18Fisher Scientific Company L.L.C.$720Consulting FeeCash or cash equivalent2023
2023-12-18Fisher Scientific Company L.L.C.$523Consulting FeeCash or cash equivalent2023
2023-12-18Fisher Scientific Company L.L.C.$374Consulting FeeCash or cash equivalent2023
2023-12-18Fisher Scientific Company L.L.C.$328Consulting FeeCash or cash equivalent2023
2023-12-18Fisher Scientific Company L.L.C.$274Consulting FeeCash or cash equivalent2023
2023-12-18Fisher Scientific Company L.L.C.$183Consulting FeeCash or cash equivalent2023
2023-12-14GE HEALTHCARE$100Debt forgivenessCash or cash equivalent2023
2023-12-12PFIZER INC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-12-08JAZZ PHARMACEUTICALS INC.$23Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$23Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$23Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$23Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$23Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$15Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$4Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-12-08JAZZ PHARMACEUTICALS INC.$2Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYA PHASE 1/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), RECOMMENDED PHASE 2 DOSE (RP22023
2023-11-28SANOFI PASTEUR INC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-11-22Novo Nordisk AS$1,873Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-44672023
2023-11-14Novartis Pharmaceuticals Corporation$9,375Research paymentCash or cash equivalentA One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) 2023
2023-10-25Novo Nordisk AS$1,125Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-44672023
2023-10-20National Marrow Donor Program$720Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-10-18Takeda Pharmaceuticals U.S.A., Inc.$16,250Research paymentCash or cash equivalentPHASE 3, MULTICENTER, RANDOMIZED STUDY WITH 2 DIFFERENT DOSES OF PRUCALOPRIDE ADMINISTERED TO MALE AND FEMALE PEDIATRIC 2023
2023-09-30Olympus America Inc.$24Debt forgivenessIn-kind items and servicesSINGLE USE SUCTION VALVE (Sterile) Device, Endotherapy2023
2023-09-22Novo Nordisk AS$1,575Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-44672023
2023-09-18Novartis Pharmaceuticals Corporation$86,782Research paymentIn-kind items and servicesTAFINLAR Drug, OncologyAn Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabr2023
2023-09-18Fisher Scientific Company L.L.C.$1,150Consulting FeeCash or cash equivalent2023
2023-09-18Fisher Scientific Company L.L.C.$973Consulting FeeCash or cash equivalent2023
2023-09-18Fisher Scientific Company L.L.C.$583Consulting FeeCash or cash equivalent2023
2023-09-18Fisher Scientific Company L.L.C.$197Consulting FeeCash or cash equivalent2023
2023-09-18Fisher Scientific Company L.L.C.$100Consulting FeeCash or cash equivalent2023
2023-09-18Fisher Scientific Company L.L.C.$96Consulting FeeCash or cash equivalent2023
2023-09-15Novartis Pharmaceuticals Corporation$22Research paymentIn-kind items and servicesKYMRIAH Drug, OncologyA single arm phase II trial in first line high risk HR pediatric and young adult patients with Bcell acute lymphoblastic2023
2023-09-11Baxter Healthcare$36Long term medical supply or device loanIn-kind items and servicesHillrom - CP 150 Resting Electrocardiograph Device, Cardiology/Vascular Diseases2023
2023-09-07Bio-Rad Laboratories, Inc.$26Debt forgivenessCash or cash equivalentIH-1000 Device, Immunohematology2023
2023-09-05Becton, Dickinson and Company$51EducationIn-kind items and services2023
2023-08-28Novartis Pharmaceuticals Corporation$1,486Research paymentIn-kind items and servicesKYMRIAH Drug, OncologyA single arm phase II trial in first line high risk HR pediatric and young adult patients with Bcell acute lymphoblastic2023
2023-08-24E.R. Squibb & Sons, L.L.C.$1,000Research paymentCash or cash equivalentSPRYCEL Drug, OncologyPhase II Pediatric Ph+ ALL - A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib Added to Standard Chemot2023
2023-08-18Novo Nordisk AS$3,489Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novartis Pharmaceuticals Corporation$19,233Research paymentIn-kind items and servicesXOLAIR Drug, Pulmonary/Respiratory DiseasesOmalizumab Before Onset of Exacerbations URI-induc. asthma exacerbation2023
2023-08-17E.R. Squibb & Sons, L.L.C.$8,500Research paymentCash or cash equivalentOPDIVO Biological, OncologyCOOP/ISR ph I Adolescent Melanoma2023
2023-08-17Novo Nordisk AS$25Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$25Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$25Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$25Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$7Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023
2023-08-17Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-44672023

The latest 200 records of 393.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

District of ColumbiaWashington city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Washington, DC, county District of Columbia, DC, state District of Columbia; placed by its city name.

MeasurePlace (city or town)
Washington, DC
County
District of Columbia, DC
State
District of Columbia
Population B01003681,294681,294681,294
Population, 2020 census P1689,545689,545689,545
Median age B0100234.934.934.9
Under 18 B0100118.7%18.7%18.7%
65 and over B0100112.8%12.8%12.8%
Households B11001324,491324,491324,491
Foreign born B0500214.3%14.3%14.3%
Median household income B19013$109,870$109,870$109,870
Median family income B19113$155,025$155,025$155,025
Per capita income B19301$77,348$77,348$77,348
Poverty rate B1700115.4%15.4%15.4%
Unemployment rate B230256.3%6.3%6.3%
Civilian labor force B23025400,406400,406400,406
Mean commute (minutes) B0801330.030.030.0
Bachelor's degree or higher B1500364.2%64.2%64.2%
Housing units B25001361,014361,014361,014
Owner-occupied B2500341.5%41.5%41.5%
Renters B2500358.5%58.5%58.5%
Median home value B25077$737,100$737,100$737,100
Median gross rent B25064$1,954$1,954$1,954
White, not Hispanic B0300236.5%36.5%36.5%
Black B0300241.6%41.6%41.6%
Hispanic or Latino B0300211.9%11.9%11.9%
Asian B030024.3%4.3%4.3%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 5.6% in Sep 2026 (6.6% a year earlier); per capita personal income $119,772 in 2025, up 32% in five years (+6.5% after inflation); Unemployment rate: 6.3% in Sep 2016 to 5.6% in Sep 2026; low 4.0%, high 11.3% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Washington, DC.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.